Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients

BACKGROUNDCenters for Disease Control and Prevention guidelines recommend caution in prescribing opioids for chronic pain. The characteristics of opioid prescription (OpRx) among kidney transplant (KTx) recipients have not been described in a national population. METHODSWe assessed OpRx prevalence a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2018-06, Vol.102 (6), p.994-1004
Hauptverfasser:	Abbott, Kevin C, Fwu, Chyng-Wen, Eggers, Paul W, Eggers, Anne W, Kline, Prudence P, Kimmel, Paul L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Analgesics, Opioid - administration & dosage Analgesics, Opioid - adverse effects Centers for Medicare and Medicaid Services, U.S Chronic Pain - diagnosis Chronic Pain - drug therapy Chronic Pain - mortality Drug Prescriptions Female Graft Survival - drug effects Humans Incidence Kidney Transplantation - adverse effects Kidney Transplantation - mortality Male Medicare Part D Middle Aged Prevalence Registries Retrospective Studies Risk Factors Time Factors Transplant Recipients United States - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	BACKGROUNDCenters for Disease Control and Prevention guidelines recommend caution in prescribing opioids for chronic pain. The characteristics of opioid prescription (OpRx) among kidney transplant (KTx) recipients have not been described in a national population. METHODSWe assessed OpRx prevalence among prevalent KTx recipients, and associated duration (long-term, defined as ≥90 days in a year) and dosing (in morphine milligram equivalents per day of
ISSN:	0041-1337 1534-6080 1534-6080
DOI:	10.1097/TP.0000000000002057